Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global sickle cell disease treatment industry is being driven by the heightened prevalence of haemoglobin diseases worldwide. As a result, increased demand for diagnosis, treatment, and prevention of haemoglobin diseases can be observed. Moreover, governments are increasingly collaborating with international organisations to raise awareness about diseases such as sickle cell diseases and organising blood donation drives among the masses while also ensuring the supply of required medicines in the adversely affected areas such as in the African region.
The rising emphasis of the leading market players in the healthcare industry to develop improved solutions for sickle cell disease treatment is expected to positively impact the industry growth. For instance, in June 2021, Global Blood Therapeutics, Inc. (NASDAQ: GBT) announced the Promising Innovative Medicine (PIM) designation assigned to their Voxelotor by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom for the potential treatment of hemolytic anaemia in adult and patients of 12 years of age with sickle cell disease (SCD). In addition, a leading gene therapy vendor, bluebird bio, Inc. (NASDAQ: BLUE), in a press release dated June 2021, announced the lifting of the FDA clinical hold on sickle cell disease and β-Thalassemia studies of LentiGlobin gene therapy, which is being tested as a one time therapy for SCD and betibeglogene autotemcel gene therapy, further helping reduce the need for blood transfusions. Such developments are expected to significantly impact the growth of the sickle cell disease treatment industry in the forecast period.
Market Breakup by Treatment and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global sickle cell disease treatment market are Emmaus Life Sciences, Inc., Global Blood Therapeutics, Inc., bluebird bio, Inc., Pfizer Inc., Novartis International AG, and others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.